HIV-Testing Companies Settle Patent Suit

Law360, New York (October 5, 2006, 12:00 AM EDT) -- StatSure Diagnostic Systems Inc. and Chembio Diagnostics Inc. have entered into agreements that will end more than two years of patent litigation between the two diagnostic testing companies.

According to the agreements, StatSure and Chembio will combine their HIV barrel intellectual property, commercialize the technology, and equally divide their share of the profits that result from the sale of Chembio’s Sure Check HIV ½ product for the detection of HIV 1 & 2 antibodies.

A third company, Inverness Medical Innovations Inc., will at the same time...
To view the full article, register now.